Mondjuk nem tisztem védeni őket vagy ilyesmi de a cég állítása szerint pont, hogy orvosi célokra lesz leginkább jó a dolog.
"[...] particularly important for research into better treatments or even cures for conditions such as epilepsy and Alzheimer’s disease, and other brain-related illnesses. [...] the CL1 system, is expected to advance research into diseases and therapeutics considerably."
"The large majority of drugs for neurological and psychiatric diseases that enter clinical trial testing fail, because there’s so much more nuance when it comes to the brain – but you can actually see that nuance when you test with these tools."